Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients.
about
Colorectal Cancer Biomarkers: Where Are We Now?The behavior of matrix metalloproteinases and their inhibitors in colorectal cancerEstablishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme.Cancer diagnosis in primary careThe diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients.Biomarkers for colorectal cancerProgressive increase of matrix metalloprotease-9 and interleukin-8 serum levels during carcinogenic process in human colorectal tract.Evaluation of alpha 1-antitrypsin and the levels of mRNA expression of matrix metalloproteinase 7, urokinase type plasminogen activator receptor and COX-2 for the diagnosis of colorectal cancerSerum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test.Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screeningRisk prediction models for colorectal cancer in people with symptoms: a systematic review.Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening.Plasma levels and diagnostic utility of VEGF, MMP-9, and TIMP-1 in the diagnosis of patients with breast cancer.Proteomic profiling of urine for the detection of colon cancer.Assessing the value of matrix metalloproteinase 9 (MMP9) in improving the appropriateness of referrals for colorectal cancer.A pilot study on faecal MMP-9: a new noninvasive diagnostic marker of colorectal cancer.Five misconceptions in cancer diagnosisPigment epithelium-derived factor and matrix metalloproteinase-9 in liver cirrhosisScreening for colorectal cancer: established and emerging modalities.Noninvasive screening tests for colorectal cancer.Diagnostic and prognostic role of matrix metalloproteases in cancer.Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets.Colorectal cancer biomarker discovery and validation using LC-MS/MS-based proteomics in blood: truth or dare?Levels of matrix metalloproteinases differ in plasma and serum - aspects regarding analysis of biological markers in cancerProfile of Expression of Genes Encoding Matrix Metallopeptidase 9 (MMP9), Matrix Metallopeptidase 28 (MMP28) and TIMP Metallopeptidase Inhibitor 1 (TIMP1) in Colorectal Cancer: Assessment of the Role in Diagnosis and Prognostication.Extracellular Matrix and Colorectal Cancer: How Surrounding Microenvironment Affects Cancer Cell Behavior?Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion.CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma.Fluorescent water soluble polymers for isozyme-selective interactions with matrix metalloproteinase-9Is serum matrix metalloproteinase 9 a useful biomarker in detection of colorectal cancer? Considering pre-analytical interference that may influence diagnostic accuracyElevated serum matrix metalloproteinase 9 concentration predicts the presence of colorectal neoplasia in symptomatic patients.Prognostic role of tumor-associated proteases in colorectal cancer.Hypertonic Saline Attenuates the Pro-metastatic Effects of LPS by Reducing Tumor Cell Migration, Proliferation and MMP-9 Expression.The matrix metalloproteinase-7 and pro-enzyme of metalloproteinase-1 as a potential marker for patients with rectal cancer without distant metastasis.Novel blood biomarkers of pancreatic cancer-associated diabetes mellitus identified by peripheral blood-based gene expression profiles.
P2860
Q27003134-4E817290-94AD-407C-BF34-A22F5884FCACQ27004958-47B25F31-C889-45A6-863B-ABDA5BCA8200Q33403635-01EC1CB3-A34A-4FBD-A658-BC09E552BE1BQ33622291-B9E2ACB5-E965-47C1-8ADD-5A79231D177CQ34084897-3511322A-8FE8-4DE0-84CA-E08211A22C65Q34205596-59BAD39A-1093-460A-A452-48014A739EA8Q34359140-347D38FB-A34F-4D0B-BC74-7E78D510C6E9Q34542024-7E162E66-6F1C-4D5A-96FB-49D43D663F00Q35889918-6A449492-4F93-4957-9FFB-EEED65A63378Q35942250-6793CB73-9BC4-4B07-BCB3-A365E77AEA4EQ36050809-C36E0F73-29A6-440B-897B-02A6E4245F3BQ36086751-C2EBA738-EDCD-44BF-8147-3C075FC8E583Q36631494-140E82BE-DBDC-4C9A-8D14-116363CB80DBQ36736959-4EF2DF1C-73B2-4014-8252-5126A2648384Q36746744-141A35D9-DE74-43F6-8196-F2FDA0259EA7Q37174910-5F667898-AC8E-4279-85A2-71EAD808B271Q37206561-CF7DEC8D-C592-4BD3-AEB5-E383F2F2B9B6Q37311888-B7C3CA5B-468B-42BA-9C4B-8EFEF48C9E7DQ37951776-7BDA9EB3-D947-491C-BA47-892DFA9FBA34Q38064739-B340108E-1F0F-4387-946B-1F975F542F34Q38089795-3C47A318-9C94-4739-B2A7-D2635395B295Q38107451-935CC1DD-F650-49A2-ADC3-B6352E2ADFACQ38202166-3E9C2304-1FA6-4AB2-AE1F-10DE445C723DQ38866279-729AE4FB-30D2-4138-BCD2-7CF462DF4662Q38908279-C440A208-8742-4440-BB0B-E2B39C12F053Q38989294-AD7BE8A5-803E-4EF7-92D0-D537FEBD3156Q39308148-26A0701F-9171-4829-A9D5-0FCF826B3361Q39688352-B8761FE2-E9A4-46D5-83C7-8BB652344124Q42087150-6B84D9F3-E468-4A8A-AC50-721B9EB89983Q42424812-FBDC1869-DCE5-4825-8C81-9B4A6969E5F4Q43234432-6E924B48-76E0-4125-8BD8-3400EC762AFDQ44182376-8EC7509C-C77C-4A1B-B6B3-B4252CA370D7Q47108514-7F7436F5-4E96-4CF9-8AFE-3A49992CE764Q53655377-98EC046F-8D3E-4185-B71A-18B2A0039273Q54422958-FE26EA4C-4FE4-4B8A-893A-54DED3412A63
P2860
Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Elevated serum matrix metallop ...... lasia in symptomatic patients.
@ast
Elevated serum matrix metallop ...... lasia in symptomatic patients.
@en
type
label
Elevated serum matrix metallop ...... lasia in symptomatic patients.
@ast
Elevated serum matrix metallop ...... lasia in symptomatic patients.
@en
prefLabel
Elevated serum matrix metallop ...... lasia in symptomatic patients.
@ast
Elevated serum matrix metallop ...... lasia in symptomatic patients.
@en
P2093
P2860
P356
P1476
Elevated serum matrix metallop ...... plasia in symptomatic patients
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603958
P407
P577
2007-10-02T00:00:00Z